Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009

키워드

참고문헌 (40)

1. Hsueh PR, "Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends)", Int J Antimicrob Agents, 36, pp.408~414 (2010)
2. Samuelsen O, "Molecular epidemiology of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion", Antimicrob Agents Chemother, 54, pp.346~352 (2010)
3. Leclercq R, "Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium", N Engl J Med, 319, pp.157~161 (1988)
4. Uttley AH, "Vancomycin-resistant enterococci", Lancet, 1, pp.57~58 (1988)
5. Périchon B, "VanA-type vancomycin-resistant Staphylococcus aureus", Antimicrob Agents Chemother, 53, pp.4580~4587 (2009)
6. Yigit H, "Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae", Antimicrob Agents Chemother, 45, pp.1151~1161 (2001)
7. Walsh TR, "Metallo-β-lactamases: the quiet before the storm", Clin Microbiol Rev, 18, pp.306~325 (2005)
8. Yong D, "Characterization of a New Metallo-beta-Lactamase Gene, bla(NDM-1), and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India", Antimicrobial Agents And Chemotherapy, 53(12), pp.5046~5054 (2009)
9. Morris AK, "Antibiotic resistance surveillance: action for international studies", J Antimicrob Chemother, 49, pp.7~10 (2002)
10. Chong Y, "Korean Nationwide Surveillance of Antimicrobial Resistance of bacteria in 1997", Yonsei Med J, 39, pp.569~577 (1998)
11. 이경원, "Increase of Ceftazidime- and Fluoroquinolone-Resistant Klebsiella pneumoniae and Imipenem-Resistant Acinetobacter spp. in Korea: Analysis of KONSAR Study Data from 2005 and 2007", Yonsei Medical Journal, 51(6), pp.901~911 (2010), 연세대학교의과대학
12. Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement, M100-S19" (2009), CLSI
13. Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement, M100-S21" (2011), CLSI
14. O’Brien TF, "WHONET: removing obstacles to the full use of information about antimicrobial resistance", Diagn Microbiol Infect Dis, 25, pp.162~168 (1996)
15. Fridkin SK, "Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals", Emerg Infect Dis, 8, pp.697~701 (2002)
16. Van Beneden CA, "Aggregated antibiograms and monitoring of drug-resistant Streptococcus pneumoniae", Emerg Infect Dis, 9, pp.1089~1095 (2003)
17. Sahm DF, "Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database-USA", Clin Infect Dis, 29, pp.259~263 (1999)
18. Felmingham D, "The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections", J Antimicrob Chemother, 45, pp.191~203 (2000)
19. Giske CG, "ESCMID Study Group on Antimicrobial Resistance Surveillance (ESGARS). Supranational surveillance of antimicrobial resistance: the legacy of the last decade and proposals for the future", Drug Resist Updat, 13, pp.93~98 (2010)
20. Clinical and Laboratory Standards Institute, "Analysis and presentation of cumulative antimicrobial susceptibility test data; Approved guideline-Third Edition. M39-A3" (2008), CLSI
21. Halstead DC, "Reality of developing a community-wide antibiogram", J Clin Microbiol, 42, pp.1~6 (2004)
22. Jones RN, "Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia", Clin Infect Dis, 51(Suppl 1), pp.S81~S87 (2010)
23. Llata E, "Measuring the scope and magnitude of hospital-associated infection in the United States: the value of prevalence surveys", Clin Infect Dis, 48, pp.1434~1440 (2009)
24. Peleg AY, "Hospital-acquired infections due to gram-negative bacteria", N Engl J Med, 362, pp.1804~1813 (2010)
25. Rosenthal VD, "International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009", Am J Infect Control, 38, pp.95~104 (2010)
26. Zhao WH, "β-lactamases identified in clinical isolates of Pseudomonas aeruginosa", Crit Rev Microbiol, 36, pp.245~258 (2010)
27. Lee K, "Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea", International Journal Of Antimicrobial Agents, 33(6), pp.520~524 (2009)
28. Falagas ME, "The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa", J Med Microbiol, 55, pp.1619~1629 (2006)
29. Kallen AJ, "Current epidemiology of multidrug resistant gram negative bacilli in the United States", Infect Control Hosp Epidemiol, 31(Suppl 1), pp.S51~S54 (2010)
30. Ko KS, "High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 60(5), pp.1163~1167 (2007), OXFORD UNIV PRESS
31. Bae S, "Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance", Antimicrob Agents Chemother, 54, pp.65~71 (2010)
32. Ramsey AM, "Secular trends of hospitalization with vancomycin-resistant Enterococcus infection in the United States, 2000-2006", Infect Control Hosp Epidemiol, 30, pp.184~186 (2009)
33. Hidron AI, "NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007", Infect Control Hosp Epidemiol, 29, pp.996~1011 (2008)
34. Jones RN, "Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: report from the SENTRY Antimicrobial Surveillance Program (1998-2009)", Diagn Microbiol Infect Dis, 68, pp.334~336 (2010)
35. Watanabe M, "Transferable imipenem resistance in Pseudomonas aeruginosa", Antimicrob Agents Chemother, 35, pp.147~151 (1991)
36. Salabi AE, "First report of the metallo-β-lactamase SPM-1 in Europe", Antimicrob Agents Chemother, 54, pp.582~ (2010)
37. Rhee JY, "KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea", Antimicrob Agents Chemother, 54, pp.2278~2279 (2010)
38. Dumartin C, "Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007", J Antimicrob Chemother, 65, pp.2028~2036 (2010)
39. Sykes R, "The 2009 Garrod lecture: the evolution of antimicrobial resistance: a Darwinian perspective", J Antimicrob Chemother, 65, pp.1842~1852 (2010)
40. Woodford N, "Infections caused by Gram-positive bacteria: a review of the global challenge", J Infect, 59(Suppl 1), pp.S4~S16 (2009)

관련 논문AI추천